Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas de Tribolet

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Neurosurgical Focus|January 2, 2015
Introduction: a focus on low-grade gliomaBob S Carter, E Antonio Chiocca, Russell Lonser, et al.
Journal of Neuro-Oncology|September 4, 2003
Survivin in brain tumors: an attractive target for immunotherapyMasahito Katoh, Rick Wilmotte, Marie-Claude Belkouch, et al.
Stroke|March 22, 2003
Cervical sympathetic block to reverse delayed ischemic neurological deficits after aneurysmal subarachnoid hemorrhageMiriam M Treggiari, Jacques-André Romand, Jean-Baptiste Martin, et al.
Pituitary|July 13, 2005
Non-functioning pituitary carcinomaPetra Nadja Elsässer Imboden, François-Xavier Borruat, Nicolas De Tribolet, et al.
European Neurology|September 8, 2007
Monovoxel 1H magnetic resonance spectroscopy in the progression of gliomasAlessandro Alimenti, Jacqueline Delavelle, François Lazeyras, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2007
Brain microenvironment promotes the final functional maturation of tumor-specific effector CD8+ T cellsFrédérick Masson, Thomas Calzascia, Wilma Di Berardino-Besson, et al.
Medicine|May 10, 2005
Apoplexy in pituitary macroadenoma: eight patients presenting in 12 monthsPetra Nadja Elsässer Imboden, Nicolas De Tribolet, Alexander Lobrinus, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 27, 2002
Unlabelled iododeoxyuridine increases the rate of uptake of [125I]iododeoxyuridine in human xenografted glioblastomasYves M Dupertuis, Wei-Hong Xiao, Nicolas De Tribolet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2003
Cutting edge: cross-presentation as a mechanism for efficient recruitment of tumor-specific CTL to the brainThomas Calzascia, Wilma Di Berardino-Besson, Rick Wilmotte, et al.
Neuroreport|June 24, 2005
B7-homolog 1 expression by human glioma: a new mechanism of immune evasionRick Wilmotte, Karim Burkhardt, Vincent Kindler, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Neurosurgical Focus|January 2, 2015
Introduction: a focus on low-grade gliomaBob S Carter, E Antonio Chiocca, Russell Lonser, et al.
Journal of Neuro-Oncology|September 4, 2003
Survivin in brain tumors: an attractive target for immunotherapyMasahito Katoh, Rick Wilmotte, Marie-Claude Belkouch, et al.
Stroke|March 22, 2003
Cervical sympathetic block to reverse delayed ischemic neurological deficits after aneurysmal subarachnoid hemorrhageMiriam M Treggiari, Jacques-André Romand, Jean-Baptiste Martin, et al.
Pituitary|July 13, 2005
Non-functioning pituitary carcinomaPetra Nadja Elsässer Imboden, François-Xavier Borruat, Nicolas De Tribolet, et al.
European Neurology|September 8, 2007
Monovoxel 1H magnetic resonance spectroscopy in the progression of gliomasAlessandro Alimenti, Jacqueline Delavelle, François Lazeyras, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2007
Brain microenvironment promotes the final functional maturation of tumor-specific effector CD8+ T cellsFrédérick Masson, Thomas Calzascia, Wilma Di Berardino-Besson, et al.
Medicine|May 10, 2005
Apoplexy in pituitary macroadenoma: eight patients presenting in 12 monthsPetra Nadja Elsässer Imboden, Nicolas De Tribolet, Alexander Lobrinus, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 27, 2002
Unlabelled iododeoxyuridine increases the rate of uptake of [125I]iododeoxyuridine in human xenografted glioblastomasYves M Dupertuis, Wei-Hong Xiao, Nicolas De Tribolet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2003
Cutting edge: cross-presentation as a mechanism for efficient recruitment of tumor-specific CTL to the brainThomas Calzascia, Wilma Di Berardino-Besson, Rick Wilmotte, et al.
Neuroreport|June 24, 2005
B7-homolog 1 expression by human glioma: a new mechanism of immune evasionRick Wilmotte, Karim Burkhardt, Vincent Kindler, et al.
Pageof 5